Patents by Inventor Jonathan Robert Sanders Arch

Jonathan Robert Sanders Arch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7241756
    Abstract: A method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: July 10, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Jonathan Robert Sanders Arch, James Martin Lenhard
  • Patent number: 7078397
    Abstract: Disclosed is a method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: July 18, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Jonathan Robert Sanders Arch, James Martin Lenhard
  • Publication number: 20030166578
    Abstract: A method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.
    Type: Application
    Filed: February 20, 2003
    Publication date: September 4, 2003
    Inventors: Jonathan Robert Sanders Arch, James Martin Lenhard
  • Publication number: 20030092126
    Abstract: A leptin or ob peptide or a functional derivative, analogue or variant thereof, which modulates body weight substantially by means of modulating energy utilisation, a pharmaceutical composition containing such a compound, a process for the preparation of such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: November 7, 2002
    Publication date: May 15, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Kamal A. Al-Barazanji, Jonathan Robert Sanders Arch, Patrick Camilleri, William Arthur Neville
  • Publication number: 20030073644
    Abstract: A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a beta agonist and another antidiabetic agent, to a mammal in need thereof.
    Type: Application
    Filed: September 13, 2002
    Publication date: April 17, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventor: Jonathan Robert Sanders Arch
  • Publication number: 20020037553
    Abstract: A leptin or ob peptide or a functional derivative, analogue or variant thereof, which modulates body weight substantially by means of modulating energy utilization, a pharmaceutical composition containing such a compound, a process for the preparation of such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: April 27, 2001
    Publication date: March 28, 2002
    Inventors: Kamal A. Al-Barazanji, Jonathan Robert Sanders Arch, Patrick Camilleri, William Arthur Neville